Criterion-Learning Practice for Aphasia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to help people with aphasia, a language disorder often caused by a stroke, improve their word-finding and usage skills. The treatment, called criterion-learning practice, involves practicing word retrieval and comprehension in multiple sessions to determine its effectiveness in supporting traditional speech therapy. It targets English-speaking adults who experienced a stroke more than six months ago and have difficulty understanding words. Participants should not have other neurological conditions such as Multiple Sclerosis or Parkinson's Disease. As an unphased trial, this study provides participants the opportunity to contribute to innovative research that could enhance future aphasia treatments.
Do I need to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this lexical treatment is safe for people with aphasia?
Research has shown that the learning practice used for aphasia is generally well-tolerated by patients. In past studies, this method helped people improve their ability to find and use words through specific exercises. Participants in these studies did not report any major side effects, suggesting that the treatment is safe for people with aphasia. However, it's important to remember that this treatment is still being tested, so individual experiences may differ.12345
Why are researchers excited about this trial?
Researchers are excited about the criterion-learning practice for aphasia because it offers a fresh approach to improving language skills in individuals with this condition. Unlike traditional speech therapy, which often relies on repetitive exercises and drills, this technique focuses on helping patients learn by setting specific, personalized goals or "criteria" for success. This could make the therapy more engaging and tailored to each person's needs, potentially leading to better outcomes in regaining communication abilities. The emphasis on individualized learning paths might make the process more effective and enjoyable for patients.
What evidence suggests that criterion-learning practice is effective for aphasia?
Research has shown that a specific type of practice can help people with aphasia, a language disorder often caused by a stroke, improve their ability to find and use words. Studies have found that spreading out learning sessions over time, known as distributed practice, enhances long-term word recall in people with aphasia. This method involves practicing word recall until reaching a certain skill level, which strengthens language abilities. Early results suggest that this approach can improve how people with aphasia process and remember words, potentially leading to better communication. By focusing on both speaking and understanding language, this treatment effectively supports traditional speech therapy.26789
Who Is on the Research Team?
Erica L Middleton, PhD
Principal Investigator
Albert Einstein Healthcare Network
Are You a Good Fit for This Trial?
This trial is for individuals with aphasia, a language disorder often caused by stroke. Participants should have difficulty with word retrieval during speech and comprehension. The study aims to help those across various severity levels of lexical processing deficits in naming and/or comprehension.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo criterion-learning naming treatment to improve word processing deficits
Follow-up
Participants are monitored for transfer of naming treatment to comprehension performance
What Are the Treatments Tested in This Trial?
Interventions
- Criterion-learning practice
Find a Clinic Near You
Who Is Running the Clinical Trial?
Albert Einstein Healthcare Network
Lead Sponsor
Thomas Jefferson University
Collaborator
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator